Marathon Man  

Oleh:

[s.n]

Jenis: Article from Bulletin/Magazine
Dalam koleksi: The Economist (http://search.proquest.com/) vol. 395 no. 8687 (Jun. 2010), page 5.
Topik: Lighten Our Darkness
Fulltext: Marathon man.pdf (913.72KB)

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: EE29.61 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

By now, if you had believed the more bullish pronouncements made at the time the humangenome project was coming to fruition, the pipelines of pharmaceutical companies would have been bursting with aspiring treatments for everything from Alzheimer’s disease to ZollingerEllison syndrome, as the genes involved in these illnesses were identified and drug molecules that could correct malfunctions of those genes were discovered. In fact, the pipelines are empty; company analysts often seem to regard research as a drain on the balancesheet, rather than an asset; and drug companies seem to be reinventing themselves as marketing firms for established products. The explanation is a toxic mix of science and economics, but the result is an industry ripe for disruption.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali